Lee v. Banner Health (Full Text)

COLORADO COURT OF APPEALS

Court of Appeals No.: 08CA0665
Weld County District Court No. 05CV1398
Honorable Daniel S. Maus, Judge

James Lee, M.D.; Jeffrey Lee, M.D.; and Front Range Surgical Specialists, Inc.,
a Colorado corporation,

Plaintiffs-Appellants,

v.

Banner Health, an Arizona non-profit corporation; Banner Health d/b/a North
Colorado Medical Center; Donald Mellman, individually and as a former
employee of Banner Health; Les Fraser, M.D., individually and as a partner in
Greeley Medical Clinic; Rick Kiser, M.D., individually and as a partner in
Greeley Medical Clinic; Lisa Burton, M.D., individually and as a partner in
Surgical Associates of Greeley; Gene O’Hara, as Chief Executive Officer of North
Colorado Medical Center; Peter S. Fine, as a member of the Banner Health
Board of Directors and as Chief Executive Officer and President of Banner
Health; Banner Health Board of Directors; and Appellate Review Committee of
Banner Health,

Defendants-Appellees.

JUDGMENT AFFIRMED IN PART, REVERSED IN PART,
AND CASE REMANDED WITH DIRECTIONS

Division I
Opinion by: JUDGE LICHTENSTEIN
Taubman and Román, JJ., concur

Announced: July 9, 2009

Charles H. Torres, P.C., Charles H. Torres, Denver, Colorado, for Plaintiffs-
Appellants

McConnell, Siderius, Fleischner, Houghtaling & Craigmile, LLC, Linda L.
Siderius, Robert W. Steinmetz, Denver, Colorado, for Defendants-Appellees

Banner Health, Banner Health d/b/a North Colorado Medical Center, and
Donald Mellman

Budman & Hershey, LLC, Kari M. Hershey, Denver, Colorado, for Defendants-
Appellees Les Fraser, M.D. and Rick Kiser, M.D.

Hill & Robbins, P.C., John F. Walsh, III, Jennifer H. Hunt, Denver, Colorado,
for Defendants-Appellees Lisa Burton, M.D., Gene O’Hara, Peter S. Fine,
Banner Health Board of Directors, and Appellate Review Committee of Banner
Health

This appeal raises issues of subject matter jurisdiction under

the Colorado Professional Review Act (CPRA), sections 12-36.5-101

to -203, C.R.S. 2008, and immunity under the Health Care Quality

Improvement Act of 1986 (HCQIA), 42 U.S.C. §§ 11101 to -11152.

Plaintiffs, Drs. James Lee and Jeffrey Lee, and their clinic,

Front Range Surgical Specialists, Inc. (Front Range), filed a

complaint in district court asserting various common law claims

against defendants, Drs. Donald Mellman, Les Fraser, Rick Kiser,

and Lisa Burton, Banner Health, the North Colorado Medical Center

(NCMC), Gene O’Hara, Peter S. Fine, the Banner Health Board of

Directors, and the Appellate Review Committee of Banner Health.

Plaintiffs alleged defendants improperly denied trauma privileges to

Dr. James Lee (Dr. Lee) and subjected him to a deficient peer review

process in retaliation for plaintiffs’ refusal to support defendants’

business decision to restrict the performance of endoscopies.

Defendants assert they engaged in an appropriate peer review

process.

The trial court dismissed plaintiffs’ claims for lack of subject

matter jurisdiction based on their failure to exhaust administrative

remedies under the CPRA, and therefore did not reach defendants’
1

immunity claim under the HCQIA. We reverse the judgment of the

district court to the extent it dismissed (1) Dr. Lee’s claims for

defamation and invasion of privacy that were based on the alleged

“public denouncement” of Dr. Lee and (2) the claims made by Dr.

Jeffrey Lee and Front Range (except for the breach of contract

claim, which is not before us on appeal). We affirm the judgment in

all other respects and remand the case to the district court for a

hearing on defendants’ claim of HCQIA immunity and for further

proceedings consistent with this opinion.

I. Background

Dr. Lee and Dr. Jeffrey Lee are brothers who operate their own

medical practice, Front Range, in Greeley, Colorado. The brothers

had privileges at Greeley’s NCMC to provide oncology care, surgery,

and trauma care.

For over six years, plaintiffs and defendants have disputed the

circumstances surrounding Dr. Lee’s departure from trauma call at

NCMC. According to plaintiffs’ complaint, in early 2003, defendant

Dr. Fraser, a member of a medical clinic and chair of NCMC’s

Surgical Quality Improvement (SQI) committee, threatened Dr. Lee’s

brother, Dr. Jeffrey Lee, with the loss of trauma privileges at NCMC
2

if the brothers would not support the efforts of Dr. Fraser and other

defendants to limit the performance of endoscopy procedures to

gastroenterology specialists.

Sometime after this initial incident, defendant Dr. Burton, a

partner in another medical group and chair of NCMC’s Trauma

Quality Improvement committee, warned Dr. Lee that plaintiffs

would have to “either get on board” with the efforts to allow only

specialists to perform endoscopy procedures or “be branded as

troublemakers.”

Plaintiffs allege that when they resisted, Dr. Burton, acting

outside NCMC’s recognized peer review procedures, called a meeting

(on July 9, 2003) with Drs. Fraser and Mellman and Ruth Sens to

discuss an “emergency situation” concerning Dr. Lee and four

allegedly mishandled trauma cases. At the time of the meeting, Dr.

Mellman was NCMC’s Associate Administrator of Medical Affairs,

and Ruth Sens was director of Quality Improvement.

The meeting participants apparently agreed that Dr. Mellman

would take immediate action against Dr. Lee, and that the four

allegedly mishandled trauma cases would be referred both for

outside review and for review by NCMC’s SQI committee. Plaintiffs
3

allege that under NCMC peer review rules, the SQI committee was

not empowered to review trauma cases.

Plaintiffs allege that on July 10, 2003, Dr. Mellman threatened

Dr. Lee with immediate suspension and reporting to the National

Practitioner Data Bank unless he voluntarily resigned his trauma

privileges. At the insistence of Dr. Mellman, Dr. Lee drafted a letter

resigning his trauma privileges. When Dr. Lee gave the letter to

him, Dr. Mellman berated Dr. Lee in a public area at NCMC where

other members of the medical staff were within earshot. Dr.

Mellman later informed Dr. Lee, in the presence of medical staff,

that because the resignation letter was improperly worded, Dr.

Mellman would still be required to report him to the National

Practitioner Data Bank unless he rewrote the letter. Plaintiffs

assert that Dr. Mellman’s threats coerced Dr. Lee to “voluntarily

waive his rights” to protections available under the hospital’s peer

review process. When Dr. Lee tried to rescind his “voluntary

resignation,” Dr. Mellman again threatened him with immediate

reporting to the National Practitioner Data Bank.

Plaintiffs allege that shortly after this public confrontation, Dr.

Mellman directed four NCMC hospital personnel to approach Dr.
4

Lee, who, at the time, was preparing to assist another doctor with a

surgical operation. They asked if he had spoken to Dr. Mellman,

telling him that he “was not to operate until he had talked with [Dr.]

Mellman.”

Plaintiffs further allege that on January 23, 2004, as Dr. Lee

was again preparing for surgery, he was handed, in a manner

calculated to create a public display, a letter stamped seven times:

“CONFIDENTIAL.” Some NCMC hospital employees approached Dr.

Lee before he was about to commence surgery to ensure he had

received this confidential letter.

Plaintiffs assert that defendants did not follow the peer review

process dictated by the NCMC bylaws for approximately seven

months – from July 10, 2003, when Dr. Mellman allegedly directed

Dr. Lee to resign from trauma call until February 27, 2004, when

defendant Dr. Kiser, who was chair of NCMC’s Credentials

Committee, notified Dr. Lee of the Credentials Committee’s receipt

of a formal request from the SQI committee for investigative and

corrective action.

Plaintiffs filed a complaint in federal district court raising

federal and state antitrust claims and other state law claims. In
5

May 2005, the federal district court dismissed the antitrust claims

with prejudice. It dismissed the remaining state claims, without

prejudice, for want of subject matter jurisdiction. In August 2005,

plaintiffs filed a complaint in state district court raising state claims

substantially similar to those brought in federal district court for (1)

civil conspiracy, (2) breach of contract, (3) tortious interference with

contract, (4) defamation and intentional interference with

contractual relations, (5) invasion of privacy, (6) negligence, (7)

liability based on ratification and failure to conduct an independent

investigation. Plaintiffs’ complaint also included a request for

exemplary damages.

On September 14, 2005, Dr. Lee received notice of a final

decision by the Banner Health Board of Directors (Board) accepting

the recommendation of Banner’s Appellate Review Committee. In

light of Dr. Lee’s receipt of the Board’s final decision, plaintiffs filed

an amended complaint on November 7, 2005 reflecting the final

decision.

Prior to the filing of the amended complaint, on October 28,

2005, defendants filed two motions to dismiss plaintiffs’ complaint,

asserting that (1) the district court lacked subject matter
6

jurisdiction over plaintiffs’ claims because plaintiffs failed to

exhaust their administrative remedies under the CPRA by not filing

their claims with the state Committee on Anticompetitive Conduct

(CAC); (2) defendants were immune from suit under the CPRA and

the HCQIA; and (3) plaintiffs’ claims for breach of contract, invasion

of privacy, and negligence failed to state claims upon which relief

could be granted.

Although defendants styled their motions as motions to

dismiss, the district court noted that the parties had attached

numerous exhibits relevant to some of the claims. It therefore

treated defendants’ motions as motions for summary judgment, but

considered the claims for breach of contract, invasion of privacy,

and negligence under C.R.C.P. 12(b)(5).

On June 19, 2007, the district court partially denied

defendants’ motions. It first concluded that because the CAC has

no power to award monetary relief, plaintiffs were not required to

file their claims with the CAC in order to properly exhaust their

administrative remedies under the CPRA. Next, the court ordered a

hearing to determine the validity of defendants’ assertions of HCQIA

and CPRA immunity. The court then found that plaintiffs had
7

successfully stated claims for invasion of privacy and negligence,

but dismissed plaintiffs’ claim for breach of contract for failure to

state a claim. Plaintiffs’ breach of contract claim is not at issue in

this appeal.

On October 30, 2007, defendants filed a joint motion for

reconsideration of their motions to dismiss in light of the supreme

court decision in Crow v. Penrose-St. Francis Healthcare System,

169 P.3d 158 (Colo. 2007), which held that common law claims

arising out of the peer review process may not be asserted in court

until a physician has exhausted his or her administrative remedies

under the CPRA. In their response, plaintiffs asserted that they

were not required to file their claims “with the CAC because none of

their allegations . . . alleged anticompetitive conduct by the

defendants.”

The district court, relying on Crow, dismissed all of plaintiffs’

claims with prejudice based on Dr. Lee’s failure to exhaust

administrative remedies under the CPRA. Contrary to plaintiffs’

position, the district court found “the conduct with which Plaintiffs

take issue [is] irreversibly intertwined with alleged anti-competitive

conduct by Defendants.” Plaintiffs appeal the judgment of
8

dismissal.

II. Standard of Review

A trial court may consider any competent evidence pertaining

to a C.R.C.P. 12(b)(1) motion to dismiss for lack of subject matter

jurisdiction without converting the motion to a summary judgment

motion. Trinity Broad. of Denver, Inc. v. City of Westminster, 848

P.2d 916, 924 (Colo. 1993).

A trial court’s determination regarding subject matter

jurisdiction is a question of law and is therefore subject to de novo

review. Pfenninger v. Exempla, Inc., 12 P.3d 830, 833 (Colo. App.

2000) (Pfenninger I) (trial court’s determination regarding subject

matter jurisdiction is reviewed de novo).

III. Discussion

Pursuant to C.R.C.P. 12(b)(1), a plaintiff has the burden of

proving that the trial court has jurisdiction to hear the case.

Pfenninger I, 12 P.3d at 833. If a party fails to exhaust

administrative remedies when required, the trial court is without

jurisdiction to hear the case. Id.; see also State v. Golden’s Concrete

Co., 962 P.2d 919, 923 (Colo. 1998).

Section 12-36.5-106 of the CPRA provides a two-track
9

exhaustion requirement for claims arising out of the peer review

process, “depending on whether the claim alleges anticompetitive

conduct by the peer review committee.” Crow, 169 P.3d at 165. To

exhaust administrative remedies for claims arising out of the peer

review process that do not allege anticompetitive conduct, a

physician need only obtain a final board action by the hospital. §

12-36.5-106(8); Crow, 169 P.3d at 165. To exhaust administrative

remedies for claims arising out of the peer review process that allege

anticompetitive conduct, a physician must obtain a final board

action by the hospital, and then present his or her claims alleging

anticompetitive conduct to the CAC. § 12-36.5-106(7) (“Any

physician . . . who believes that [a final board] action resulted from

unreasonable anticompetitive conduct shall have, as his sole and

exclusive remedy, direct review of the record by the [CAC].”); Crow,

169 P.3d at 163.

The CAC’s jurisdiction does not extend to the review of a

hospital’s denial of a physician’s privileges when the denial is

unrelated to the physician’s qualifications, conduct, or quality of

patient care. Ryals v. St. Mary-Corwin Reg’l Med. Ctr., 10 P.3d 654,

662 (Colo. 2000).

10

Plaintiffs contend the district court had subject matter

jurisdiction over their claims because the CPRA exhaustion

requirement did not require them to present their claims to the CAC

prior to filing in district court. They specifically assert that (1) their

complaint alleged retaliatory conduct as opposed to anticompetitive

conduct; or (2) assuming arguendo that the alleged conduct was

anticompetitive, the conduct did not stem from a peer review

process.

As a preliminary matter, we note that the procedural posture

of the plaintiffs is distinct. Dr. Lee is the only plaintiff that was the

subject of peer review. Therefore we will analyze the CPRA

exhaustion requirement separately as to Dr. Lee and the other two

plaintiffs, Dr. Jeffrey Lee and Front Range.

A. Dr. Jeffrey Lee and Front Range

Dr. Jeffrey Lee and Front Range contend the court erred by

dismissing their claims because they have damages that exist

independently of Dr. Lee’s claims. Defendants assert that the

claims of Dr. Jeffrey Lee and Front Range are derivative of Dr. Lee’s

claims and are “per se precluded” by the CPRA’s exhaustion

requirement in section 12-36.5-106(7) due to Dr. Lee’s failure to
11

present his claims to the CAC. We agree with Dr. Jeffrey Lee and

Front Range.

In its order dismissing plaintiffs’ amended complaint, the

district court did not explain its rationale – beyond its reliance on

Crow – for dismissing claims made by Dr. Jeffrey Lee and Front

Range. Consequently, we infer that the district court dismissed

their claims because it believed them to be barred by Dr. Lee’s

failure to bring his own claims before the CAC.

In Ryals, our supreme court held that only claims arising out

of the peer review process are subject to the CPRA’s exhaustion of

remedies requirement. Ryals, 10 P.3d at 659. In addition, section

12-36.5-106(7) unambiguously states that only physicians who are

“the subject of a final action by a governing board” need present

peer review claims that allege anticompetitive conduct to the CAC.

Crow, 169 P.3d at 165. In the present case, neither Dr. Jeffrey Lee

nor Front Range was subject to peer review, and neither was the

subject of a final action by a governing board. Thus, they had no

avenue for relief other than to bring their claims in district court.

In addition, the civil conspiracy, interference with contract,

and liability based on ratification and failure to conduct an
12

independent investigation claims brought by Dr. Jeffrey Lee and

Front Range (as well as their request for exemplary damages) were

not dependent upon Dr. Lee’s recovery on his claims, and are

therefore not properly characterized as derivative. See Elgin v.

Bartlett, 994 P.2d 411, 415 (Colo. 1999) (derivative claims are

unique in that they depend entirely upon the right of the injured

person to recover). Furthermore, the invasion of privacy and

defamation claims were not subject to the CPRA’s exhaustion

requirement, as discussed below.

We therefore conclude that Dr. Lee’s failure to present his

claims to the CAC did not deprive the district court of jurisdiction

over the claims of Dr. Jeffrey Lee and Front Range.

B. Dr. Lee

We now turn to whether Dr. Lee was required to present his

claims to the CAC prior to filing in district court. We conclude that,

other than the invasion of privacy and defamation claims discussed

below, Dr. Lee was required to exhaust his claims before the CAC,

because his claims alleged anticompetitive conduct arising out of

the peer review process.

i. Anticompetitive Conduct
13

In its order dismissing Dr. Lee’s claims, the district court

found that the amended complaint alleged anticompetitive conduct,

and concluded that the “attempt to characterize [d]efendants’

purported conduct as ‘retaliation’ instead of ‘anti-competition’

amount[ed] to an issue of semantics.”

On appeal, Dr. Lee argues that retaliatory conduct is different

from anticompetitive conduct, and that his claims were based on

defendants’ retaliation for plaintiffs’ refusal to support defendants’

efforts to limit the performance of endoscopies to specialists. We

are not persuaded.

After our own review of the amended complaint, we agree with

the district court that the complaint alleges anticompetitive conduct

because it is replete with assertions such as: “Defendants conspired

and agreed to retaliate against Plaintiffs and their clinic, to destroy

competition in Greeley and northern Colorado.” Moreover, plaintiffs

describe Drs. Burton, Fraser, and Kiser as competitors, and accuse

Banner Health of allowing certain doctors to use the peer review

process to arbitrarily ruin the reputations and practices of

“competitor doctors.” Whether defendants had retaliatory motives

for engaging in anticompetitive conduct does not alter the fact that
14

Dr. Lee alleged anticompetitive conduct. See Crow, 169 P.3d at

166. Therefore, he was required to present his claims to the CAC

before bringing them in court, so long as the claims arose out of the

peer review process. § 12-36.5-106(7); Crow, 169 P.3d at 165.

ii. Peer Review

Plaintiffs contend that Dr. Lee’s claims did not arise out of a

peer review process. They argue the claims either did not involve

patient care issues or were based on conduct that occurred prior to

any official NCMC peer review procedure. With the exception of the

invasion of privacy and defamation claims that were based on Dr.

Mellman’s alleged “public denouncement of Dr. James Lee,” we

disagree with plaintiffs.

The CAC only has jurisdiction over claims arising from a peer

review activity assessing physician competence. Ryals, 10 P.3d at

659. In Ryals, the defendant hospital denied the plaintiff physician

MRI-reading privileges. Because the hospital’s denial was based on

an exclusive contract granting MRI-reading privileges to a specific

group of doctors and not on concerns about the plaintiff’s

competence, the supreme court concluded that the plaintiff

15

physician’s claims had not arisen from a peer review process, and

thus were not subject to the CPRA’s exhaustion requirements. Id.

Here, plaintiffs do not dispute that at the initial July 9, 2003

meeting among Dr. Burton, Dr. Fraser, Dr. Mellman, and Sens, the

participants reviewed four of Dr. Lee’s trauma cases.

However, plaintiffs assert that the purported peer review that

commenced at the July 9, 2003 meeting did not follow NCMC peer

review procedures, and thus could not qualify as peer review for

purposes of the CPRA. Even if we were to assume, without

deciding, that the process did not follow recognized procedures, we

are not persuaded.

Under the CPRA, peer review committees may investigate the

“quality or appropriateness of patient care rendered by or the

professional conduct of any [licensed] physician.” § 12-36.5-

104(6)(a)(II); see Ryals, 10 P.3d at 659. Since it is undisputed that

Dr. Burton, Dr. Fraser, Dr. Mellman, and Sens met on July 9, 2003

to review four of Dr. Lee’s trauma cases, the July 9 meeting

commenced Dr. Lee’s peer review process.

Failure by defendants to conduct the peer review process in

accordance with NCMC bylaws does not mean defendants were
16

engaged in something other than peer review. Rather, any alleged

failure of defendants to comply with NCMC bylaws would simply

constitute a deficiency in the peer review process. See Crow, 169

P.3d at 168 (“Crow’s complaints stem solely from the process, or in

his view, lack of process, that he has been afforded.”); see also § 12-

36.5-104(4) (professional review committee must operate pursuant

to written bylaws approved by governing board); Peper v. St. Mary’s

Hosp. & Med. Ctr., 207 P.3d 881, 888-89 (Colo. App. 2008)

(addressing adequacy of notice and hearing procedures).

Under Crow, claims based on deficiencies in the peer review

process are treated no differently from claims based on the outcome

of the peer review process. Crow, 169 P.3d at 168-69.

Consequently, we conclude that Dr. Lee’s claims regarding the

adequacy of defendants’ investigation and review of his competence

are claims arising out of the peer review process, and therefore fall

within the CAC’s jurisdiction.

Pursuant to section 12-36.5-106(7), Dr. Lee was required to

present his claims (other than invasion of privacy and defamation)

to the CAC before filing suit in district court. Id. at 163. Because

he did not do so, the district court was without jurisdiction to
17

entertain his claims, other than the below-discussed invasion of

privacy and defamation claims.

iii. Invasion of Privacy and Defamation Claims

Plaintiffs contend the court erred by dismissing their fourth

claim, for defamation, and their fifth claim, for invasion of privacy,

asserting that the CAC does not have jurisdiction over common law

claims that do not arise out of peer review activity. We agree, but

only to the extent the claims are based on Dr. Mellman’s alleged

“public denouncement of Dr. James Lee.”

As an initial matter, we note that although plaintiffs assert in

the argument heading of their brief that the court erred by

dismissing their claim for invasion of privacy, the text of their

arguments addresses their claims for invasion of privacy and

defamation to the extent they were based on public confrontations

between Drs. Mellman and Lee. We therefore address plaintiffs’

arguments regarding both claims.

Plaintiffs rely on Pfenninger v. Exempla, Inc., 17 P.3d 841

(Colo. App. 2000) (Pfenninger II), to argue that physicians are not

required to present common law claims to the CAC because the

CAC has no jurisdiction over such claims. Plaintiffs assert that the
18

supreme court’s holding in Crow does not alter Pfenninger II’s

holding. While we disagree with plaintiffs’ characterization of Crow,

we agree that the district court erred in dismissing plaintiffs’ two

claims here. Contrary to plaintiffs’ argument, Crow limits the

Pfenninger II holding, but only to the extent that a physician asserts

common law claims that arise out of a peer review activity.

Pursuant to Crow, “common law claims arising out of the peer

review procedure are subject to the exhaustion of administrative

remedies requirement detailed in subsections 12-36.5-106(7) and

(8).” Crow, 169 P.3d at 163 (emphasis added).

Here, rather than occurring during a peer review procedure,

Dr. Mellman’s alleged “public denouncement” of Dr. Lee was made

in hallways and operating rooms at NCMC. To the extent plaintiffs’

invasion of privacy and defamation claims were based on this

conduct, they were not subject to the CPRA’s exhaustion of

administrative remedies requirement under section 12-36.5-106.

We conclude, therefore, that plaintiffs were not required to present

these claims to the CAC before proceeding with them in district

court.

19

We further conclude that to the extent plaintiffs’ fourth and

fifth claims allege NCMC and Banner Health share liability for Dr.

Mellman’s alleged torts, plaintiffs were not required to first present

these claims to the CAC. We express no opinion, however, on the

validity of plaintiffs’ claims.

C. HCQIA Immunity

Defendants contend they are entitled to statutory immunity

under the HCQIA. Insofar as we have reversed the dismissal of

some of plaintiffs’ claims, we remand for the district court to

conduct a hearing on defendants’ assertion of HCQIA immunity.

D. Attorney Fees and Costs

Defendants next contend they are entitled to an award of

attorney fees and costs on appeal, citing section 13-17-201, C.R.S.

2008, which provides for the award of attorney fees in a tort action

dismissed under Crim. P. 12(b). We disagree.

Had defendants successfully defended the C.R.C.P. 12(b)

dismissal of plaintiffs’ claims on appeal, they would be entitled to

recover reasonable attorney fees on appeal. Cf. State Farm Fire &

Cas. Co. v. Weiss, 194 P.3d 1063, 1169 (Colo. App. 2008). Here,

however, because we have reinstated some of plaintiffs’ claims,
20

defendants cannot recover their attorney fees under section 13-17-

201. See Rector v. City & County of Denver, 122 P.3d 1010, 1018

(Colo. App. 2005); Sundheim v. Bd. of County Comm’rs, 904 P.2d

1337, 1353 (Colo. App. 1995) (§ 13-17-201 inapplicable because

one of the claims had been restored in part), aff’d, 926 P.2d 545

(Colo. 1996).

In light of this conclusion, we need not address plaintiffs’

remaining arguments in opposition to defendants’ request for

attorney fees.

As to costs, section 13-17-201 does not provide for an award

of costs, and because we have reinstated some of plaintiffs’ claims,

we decline to award defendants costs on appeal. See C.A.R. 39(a) (if

a judgment is affirmed or reversed in part, or is vacated, costs shall

be allowed only as ordered by the court).

IV. Conclusion

The judgment of the district court is reversed to the extent it

dismissed Dr. Lee’s claims for defamation and invasion of privacy

based on Dr. Mellman’s alleged “public denouncement” of Dr. Lee.

The judgment of the district court is also reversed to the extent it

dismissed all claims made by Dr. Jeffrey Lee and Front Range
21

(except for the breach of contract claim, which is not before us on

appeal). The judgment is affirmed in all other respects. The case is

remanded to the district court to hold a hearing to determine

defendants’ claim of HCQIA immunity and for further proceedings

consistent with this opinion.

JUDGE TAUBMAN and JUDGE ROMÁN concur.

22